These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17086063)

  • 1. Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin.
    Soriano V; Labarga P; Ruiz-Sancho A; Garcia-Samaniego J; Barreiro P
    AIDS; 2006 Nov; 20(17):2225-7. PubMed ID: 17086063
    [No Abstract]   [Full Text] [Related]  

  • 2. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Taylor LE; Rich JD; Tashima KT
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15564553
    [No Abstract]   [Full Text] [Related]  

  • 3. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Gholam PM
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15570682
    [No Abstract]   [Full Text] [Related]  

  • 4. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
    Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
    JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
    Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
    N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
    Bräu N
    Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating hepatitis C in "difficult-to-treat" patients.
    Pawlotsky JM
    N Engl J Med; 2004 Jul; 351(5):422-3. PubMed ID: 15282348
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of combined treatment with pegylated-IFN-alpha 2b plus ribavirin in HIV-hepatitis C virus-co-infected patients.
    Cinelli R; Di Gennaro G; Nasti G; Tedeschi R; Dal Maso L; Canzonieri V; Balestreri L; Fedele P; Tirelli U
    AIDS; 2004 Apr; 18(7):1079-80. PubMed ID: 15096816
    [No Abstract]   [Full Text] [Related]  

  • 9. [PEG-interferons: significance for the treatment of viral hepatitis B and C].
    Wedemeyer H; Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S68-75. PubMed ID: 11450618
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally.
    Rosso R; Di Biagio A; Mikulska M; Nicco E; Bernardini C; Viscoli C
    J Med Virol; 2010 Jul; 82(7):1110-4. PubMed ID: 20513072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin in combination therapy for HCV chronic infection in HIV patients: how to win the war after winning the first battle?
    Souvignet C; Maynard M; Gagnieu MC; Trepo C
    J Hepatol; 2007 Jul; 47(1):1-3. PubMed ID: 17509722
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients.
    De Luca A; Di Giambenedetto S; Cingolani A; Ammassari A; Marasca G; Tumbarello M; Fantoni M; Tamburrini E; Cauda R
    AIDS; 2004 Jul; 18(11):1602-4. PubMed ID: 15238782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis.
    Marrache F; Consigny Y; Ripault MP; Cazals-Hatem D; Martinot M; Boyer N; Degott C; Valla D; Marcellin P
    J Viral Hepat; 2005 Jul; 12(4):421-8. PubMed ID: 15985014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon and ribavirin: differences between pegylated and standard interferon.
    Arizcorreta A; Brun F; Fernández-Gutiérrez C; García Juárez R; Guerrero F; Pérez-Guzmán E; Girón-González JA
    Clin Microbiol Infect; 2004 Dec; 10(12):1067-74. PubMed ID: 15606633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
    Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
    AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step.
    Manns MP; Wedemeyer H
    JAMA; 2004 Dec; 292(23):2909-13. PubMed ID: 15598923
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiviral treatment in liver cirrhosis due to hepatitis C virus].
    Martínez-Bauer E; Forns X
    Gastroenterol Hepatol; 2003 May; 26(5):303-6. PubMed ID: 12732104
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.
    Bräu N
    J Antimicrob Chemother; 2005 Dec; 56(6):991-5. PubMed ID: 16308419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of combination therapy with interferon-alpha and ribavirin in patients with chronic hepatitis C coinfected with human immunodeficiency virus].
    Castéra L; Roulot D
    Gastroenterol Clin Biol; 2000 Oct; 24(10):978-9. PubMed ID: 11185920
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].
    Marcos Sánchez F; Albo Castaño MI; Casallo Blanco S
    Rev Clin Esp; 2007 Mar; 207(3):150-1; author reply 151-2. PubMed ID: 17397643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.